Here, we report that patients with EGPA have elevated levels of TSLP, IL-25, and soluble ST2, which are well-characterized cytokine “alarmins” that activate or modulate type 2 innate lymphoid cells (ILC2s). The gene discussed is TSLP; the disease is eosinophilic granulomatosis with polyangiitis.